With fewer steps and less processing time than other NAT methods, TMA technology reduces the risk of contamination and streamlines workflow for faster results.
Novartis Diagnostics offers the only two fully integrated and automated platforms for NAT blood screening.
PROCLEIX® NAT TRACKER® and Pooling Software manage results produced with PROCLEIX® Assays using PROCLEIX® Instruments.
Novartis Diagnostics' PROCLEIX® Assays are used for blood screening to detect viral RNA and DNA during the very early stages of infection.
About Novartis Vaccines
Novartis Vaccines is a leader in providing products to fight more than 20 vaccine-preventable viral and bacterial diseases. Novartis Vaccines is the division researching novel treatments.